James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Slowing Stock Buybacks One of a Few Reasons to Fear Q3 Earnings

The massive wave of stock buybacks is now in the rearview mirror, meaning earnings growth just got that much tougher.

Why Sprint Corp (S), Valeant Pharmaceuticals Intl Inc (VRX) and Energy Transfer Equity LP (ETE) Are 3 of Today’s Worst Stocks

Sprint (S), Valeant Pharmaceuticals (VRX) and Energy Transfer Equity (ETE) used far more than their fair share of red ink on Monday, which was in short supply to begin with.

For Alcoa Stock Owners, The Grass May Not Be Greener After AA Split

Alcoa stock will become two distinct investments next year, but there's a cost involved with this streak of divesting what was just recently acquired.

Why Finish Line Inc (FINL), Valeant Pharmaceuticals Intl Inc (VRX) and Micron Technology, Inc. (MU) Are 3 of Today’s Worst Stocks

Finish Line (FINL), Valeant Pharmaceuticals (VRX) and Micron Technology (MU) each fell sharply on Friday. Here's what investors need to know.

Quit the Spin: BlackBerry (BBRY) Stock Is a Dog

Fans and followers of BBRY stock are still pounding the bullish drum, but the hurdles are getting higher, and BlackBerry is getting desperate.

Gold Prices Finishing Q3 Strong, But Upside Is Limited in Q4

Don't get too jazzed about the current gold price rally. Gold prices still have a lot working against them.

Why Caterpillar Inc. (CAT), Twitter Inc (TWTR) and Energy Transfer Equity LP (ETE) Are 3 of Today’s Worst Stocks

Too bad Thursday couldn't be a do-over for Caterpillar (CAT), Twitter (TWTR) and Energy Transfer Equity (ETE). Here's the deal.

10 Cheap Pharmaceutical Stocks to Buy

Investors looking for underappreciated, underpriced pharmaceutical stocks to buy should start their hunt with this list.

Why Las Vegas Sands Corp. (LVS), JD.Com Inc (JD) and Freeport-McMoRan Inc (FCX) Are 3 of Today’s Worst Stocks

Shareholders of Las Vegas Sands (LVS), JD.Com (JD) and Freeport-McMoRan (FCX) felt a bearish wind from the Far East on Wednesday.

What Owners of BBRY Stock Need to Know Before Friday’s BlackBerry Earnings Report

One way or another, BBRY stock will take investors on a wild ride at the end of the week. Here's your pre-earnings primer.